Transgenic mice expressing IFN-γ in the epidermis have eczema, hair hypopigmentation, and hair loss

Journal of Investigative Dermatology

Volumn 108, Issue 4, 1997, Pages 412-422

  Carroll, Joseph M ^a   Crompton, Tessa ^a   Seery, John P ^a   Watt, Fiona M ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

epidermis; hair; IFN ; inflammation; melanocytes; transgenic mice

Indexed keywords

GAMMA INTERFERON; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTACT ALLERGY; ECZEMA; EPIDERMIS; HAIR LOSS; HYPOPIGMENTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN INFLAMMATION; TRANSGENIC MOUSE;

EID: 0030973604     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12289702     Document Type: Article

References (58)

1. Arata J, Abe-Matsuura Y: Generalized vitiligo preceded by a generalized figurate erthyematosquamous eruption. J Dermatol 21:438-441, 1994
2. Auböck J, Romani N, Grubauer G, Fritsch P: HLA-DR expression on keratinocytes is a common feature of diseased skin. Br J Dermatol 114:465-472, 1986
3. Baadsgaard O: Alopecia areata: an immunologiC disease? J Invest Dermatol 96:89S-90S, 1991
4. Bal V, McIndoe A., Denton G, Hudson D, Lombardi G, Lamb J, Lechler R: Antigen presentation by keratinocytes induces tolerance in human T cells, Eur Immunol 20:1893-1897, 1990
5. Barker JNWN, Alegre VA, MacDonald DM: Surface-bound immunoglobulin E on antigen-presenting cells in cutaneous tissue of atopic dermatitis. J Invest Dermatol 90:117-121, 1988
6. Barker JNWN, Allen MH, MacDonald DM: Alterations induced in normal human skin by in vivo interferon-gamma. Br J Dermatol 122:451-458, 1990
7. Barker JNWN, Allen MH, MacDonald DM: The effect of in vivo interferon-gamma on the distribution of LFA-1 and ICAM-1 in normal human skin. J Invest Dermatol 93:439-442, 1989
8. Barker JNWN, Goodlad JR, Ross EL, Yu CC, Groves RW, MacDonald DM: Increased epidermal cell proliferation in normal human skin in vivo following local administration of interferon-γ. Am J Pathol 142:1091-1097, 1993
9. Barker JNWN, Mitra RS, Griffiths CEM, Dixit VM, Nickoloff BJ: Keratinocytes as initiators of inflammation. Lancet 337:211-214, 1991
10. Carroll JM, Albers KM, Garlick JA, Harrington R, Taichman LB: Tissue- and stratum-specific expression of the human involucrin promoter in transgenic mice. Proc Natl Acad Sci USA 90:10270-10274, 1993
11. Carroll JM, Romero MR, Watt FM: Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 83:957-968, 1995
12. Cheng J, Turksen K, Yu Q-C, Schreiber H, Teng M, Fuchs E: Cachexia and graft-vs.-host-disease-type skin changes in keratin promoter-driven TNFα transgenic mice. Genes Dev 6:1444-1456, 1992
13. Domincy AM, Wang X-J, King Jr: LE, Nanney LB, Gagne TA, Sellheyer K, Bundman DS, Longley MA, Rothnagel JA, Greenhalgh DA, Roop DR: Targeted overexpression of transforming growth factor α in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Diff 4:1071-1082, 1993
14. Dustin ML, Singer KH, Tuck DT, Springer TA: Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by Interferon γ and is mediated by intercellular adhesion molecule 1 (ICAM-1). J Exp Med 167:1323-1340, 1988
15. Enk AH, Katz SI: Contact sensitivity as a model for T-cell activation in skin. J Invest Dermatol 105:80s-83s, 1995
16. Gray PW, Goeddel DV: Cloning and expression of murine immune Interferon cDNA. Proc Natl Acad Sci USA 80:5842-5846, 1983
17. Griffiths CEM, Voorhees JJ: Immunological mechanisms involved in psoriasis. Springer Semin Immunopathol 13:441-454, 1992
18. Griffiths CEM, Voorhees JJ, Nickoloff BJ: Characterization of intercellular adhesion molecule 1 and HLA-DR in normal and inflamed skin: modulation by interferon-gamma and tumor necrosis factor. J Am Acad Dermatol 20:617-629, 1989
19. Groves RW, Mizutani H, Kieffer JD, Kupper TS: Inflammatory skin disease in transgenic mice that express high levels of interleukin 1α in basal epidermis. Proc Natl Acad Sci USA 92:11874-11878, 1995
20. Gruner S, Liebenthal C, Heusser C, Brinkmann V, Zwirner A, Reinicke C, Harnack K, Sönnichsen B, Volk H-D: The influence of interferon-gamma and interleukin-4 on IgE production in B lymphocytes of patients with atopic dermatitis. Acta Derm Venereol (Stockh) 71:484-487, 1990
21. Gu D, Wogensen L, Calcutt NA, Xia C, Zhu S, Merlie JP, Fox HS, Lindstrom J, Powell HC, Sarvetnick N: Myasthenia gravis-like syndrome induced by expression of interferon y in the neuromuscular junction. J Exp Med 181:547-557, 1995
22. Heck D, Laskin DL, Gardner CR, Laskin JD: Epidermal growth factor suppresses nitric oxide and hydrogen peroxide production by keratinocytes. Potential role for nitric oxide in the regulation of wound healing. J Biol Chem 267:21277-21280, 1992
23. Hodivala KJ, Watt FM: Evidence that cadherins play a role in the down regulation of integrin expression that occurs during keratinocyte terminal differentiation. J Cell Biol 124:589-600, 1994
24. Hoffmann R, Wenzel E, Huth A, van der Steen P, Schäufele M, Henninger H-P, Happle R: Cytokine mRNA levels in Alopecia areata before and after treatment with the contact allergen diphenylcyclopropenase. J Invest Dermatol 103:530-533, 1994
25. Hopkins T, Clark RAF: The eczemas. In: Callen JP (ed.) Current Practice of Medicine, Vol. 1, Dermatology. Current Medicine, Philadelphia, PA, 1995, pp 68-76
26. Howie SEM, Aldridge RD, McVittie E, Forsey RJ, Sands C, Hunter JAA: Epidermal keratinocyte production of interferon-γ immunoreactive protein and mRNA is an early event in allergic contact dermatitis. J Invest Dermatol 106:1218-1223, 1996
27. 6 subunit gene reveals a role of epithelial integrins in regulating inflammation in the lungs and skin. J Cell Biol 133:921-928, 1996
28. Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A, Steinman RM, Nussenzweig MC: The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing. Nature 375:151-155, 1995
29. Jones PH, Watt FM: Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 73:713-724, 1993
30. Kondo S, McKenzie RC, Sauder DN: Interleukin-10 inhibits the elicitation phase of allergic contact hypersensitivity. J Invest Dermatol 103:811-814, 1994
31. Kraal G, Breel M, Janse M, Bruin G: Langerhans cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody. J Exp Med 163:981-997, 1986
32. Lee M-S, Von Herrath M, Reiser H, Oldstone MBA, Sarvetnick N: Sensitization to self (virus) antigen by in situ expression of murine interferon-y. J Clin Invest 95:486-492, 1995
33. McKenzie RC, Sauder DN: The role of keratinocyte cytokines in inflammation and immunity. J Invest Dermatol 95:105S-107S, 1990
34. Nasir A, Ferbel B, Salminen W, Barth RK, Gaspari AA: Exaggerated and persistent cutaneous delayed-type hypersensitivity in transgenic mice whose epidermal keratinocytes constitutively express B7-1 antigen. J Clin Invest 94:892-898, 1994
35. Nickoloff BJ, Mitra RS, Elder JT, Fisher GJ, Voorhees JJ: Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor-α production in keratinocytes cultured from psoriatic lesions. Br J Dermatol 121:161-174, 1989
36. Nickoloff BJ, Turka LA: Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with kerarinocytes. Immunol Today 15:464-469, 1994
37. Niizeki H, Inamoto N, Nakamura K, Tsuchimoto K, Hashimoto T, Nishikawa T: A case of pemphigus foliaceus after interferon α-2a therapy. Dermatology 189(suppl 1):129-130, 1994
38. Noelle R, Snow EC: T helper cells. Curr Opin Immunol 4:333-337, 1992
39. Okura M, Maeda M, Nishikawa S, Mizoguchi M: Effects of monoclonal anti-c-kit antibody (ACK2) on melanocytes in newborn mice. J Invest Dermatol 105:322-328, 1995
40. Piguet PF, Grau GE, Hauser C, Vassalli P: Tumor necrosis factor is a critical mediator in hapten-induced irritant and contact hypersensitivity reactions. J Exp Med 173:673-679, 1991
41. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA: Insulin-dependent Diabetes melliris induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52:773-782, 1988
42. Sarvetnick N, Shizuru J, Liggitt D, Martin L, McIntyre B, Gregory A, Parslow T, Stewart T: Loss of pancreatic islet tolerance induced by β-cell expression of interferon-γ. Nature 346:844-847, 1990
43. Saulnier M, Huang S, Aguet M, Ryffel B: Role of interferon-y in contact hypersensitivity assessed in interferon-γ receptor-deficient mice. Toxicology 102:301-312, 1995
44. Scheynius A, Fransson J, Johansson C, Hammar H, Baker B, Fry L, Valdimarsson H: Expression of interferon-gamma receptors in normal and psoriatic skin. J Invest Dermatol 98:255-258, 1992
45. Schmidt HHHW, Walter U: NO at work. Cell 78:919-925, 1994
46. Schultz RM, Kleinschmidt WJ: Functional identity between murine γ interferon and macrophage activating factor. Nature 305:239-240, 1983
47. Trinchieri G, Perussia B: Immune interferon: a pleiotropic lymphokine with multiple effects. Immunol Today 6:131-136, 1985
48. van Wilsem EJG, Brevé J, Kleijmeer M, Kraal G: Antigen-bearing Langerhans cells in skin draining lymph nodes: phenotype and kinetics of migration, J Invest Dermatol 103:217-220, 1994
49. Vassar R, Fuchs E: Transgenic mice provide new insights into the role of TGF-α during epidermal development and differentiation. Genes Dev 5:714-727, 1991
50. Vikingson A, Pederson K, Muller D: Enumeration of IFN-γ producing lymphocytes by flow cytometry and correlation with quantitative measurement of IFN-γ. J Immunol Methods 173:219-228, 1994
51. Vogel U, Denecke B, Troyanovsky SM, Leube RE, Böttger EC: Transcriptional activation of psoriasis-associated cytokeratin K17 by interferon-γ. Analysis of γ-interferon activation sites. Eur J Biochem 227:143-149, 1995
52. von Ballestrem CG, Uniyal S, McCormick JI, Chau T, Singh B, Chan BMC: VLA-β1 integrin subunit-specific monoclonal antibodies MB1.1 and MB1.2: binding to epitopes not dependent on thymocyte development or regulated by phorhol ester and divalent cations. Hybridoma 15:125-132, 1996
53. von den Driesch P, Fartasch M, Hornstein OP: Chronic actinic dermatitis with vitiligo-like depigmentation. Clin Exp Dermatol 17:38-43, 1992
54. Williams IR, Kupper TS: Epidermal expression of intercellular adhesion molecule 1 is not a primary inducer of cutaneous inflammation in transgenic mice, Proc Natl Acad Sci USA 91:9710-9714, 1994
55. Williams IR, Ort RJ, Kupper TS: Keratinocyte expression of B7-1 in transgenic mice amplifies the primary immune response to cutaneous antigens. Proc Natl Acad Sci USA 91:12780-12784, 1994
56. Williams JG, Jurkovich GJ, Maier RV: Interferon-γ: a key immunoregulatory lymphokine. J Surg Res 54:79-93, 1993
57. Yamamura K, Kamada S, Ito S, Nakagawa K, Ichihashi M, Tsujimoto Y: Accelerated disappearance of melanocytes in bcl-2-deficient mice. Cancer Res 56:3546-3550, 1996
58. Zandvliet DWJ, Hanby AM, Austin CA, Marsh GL, Clark IBN, Wright NA, Poulsom R: Analysis of fetal expression sites of human type II DNA topoisomerase a and β subunits by in situ hybridization. Biochim Biophys Acta 1307:239-247, 1996